Society for Cardiovascular Angiography Interventions (SCAI)

The Society for Cardiovascular Angiography and Interventions (SCAI) represents interventional cardiology through education, advocacy, research, setting guidelines and quality patient care. SCAI provides thought leadership in cath lab procedures, new technology and policy.

Contrast injections during angiography, PCI unlikely to cause coronary injuries
The pressure changes associated with contrast injections are minimal, researchers noted, especially once you move away from the tip of the catheter.
Charles E. Mullins remembered as a pioneer of interventional pediatric cardiology
Charles E. Mullins, MD, a U.S. Army veteran who went on to practice medicine for five decades, died at the age of 92. SCAI shared a loving tribute to Mullins, calling him the "father of modern interventional pediatric cardiology."
Cardiologists reflect on developing primary PCI in face of criticism and pushback
SCAI celebrated cardiologists William W. O'Neill, MD, and Cindy L. Grines, MD, for the important roles they played in the development of primary PCI. “It was challenging,” Grines explained. “We had the pharmaceutical industry that was anti-primary angioplasty and we had a lot of our own colleagues that were anti-primary angioplasty."
Cardiology societies push Medicare to pay for tricuspid TEER
Six multispecialty cardiovascular societies have called on CMS to approve Medicare payments for tricuspid transcatheter edge-to-edge repair (T-TEER).
SCAI shares STEMI recommendations for cardiologists and cath labs
“This document represents a collective effort to refine and advance the standards of care in STEMI management," according to one cardiologist behind the project.

SCAI publishes consensus document on PFO closure

An expert consensus statement published by the Society for Cardiovascular Angiography and Interventions (SCAI) offers guidance for the safe and effective use of patent foramen ovale (PFO) closure devices to prevent recurrent stroke.

March 25, 2019

SCAI chimes in on concerns about paclitaxel devices

The Society for Cardiovascular Angiography and Interventions (SCAI) weighed in on the ongoing debate regarding the long-term safety of paclitaxel-coated balloons and stents on Jan. 25, largely agreeing with the FDA’s stance that the benefits of such devices appear to outweigh the risks until more information becomes available.

January 28, 2019

ACC, SCAI and HRS commit to cardiovascular public reporting program

Major cardiovascular societies are increasing their public reporting of data to help patients obtain information on hospitals’ care delivery and improve the quality and cost of care, according to an advisory published online in the Journal of the American College of Cardiology on Nov. 18.

November 25, 2015

Get ready for SCAI, HRS

This is the month for subspecialty cardiology conferences in the U.S., with two major meetings setting anchors on each coast.

May 1, 2015

Around the web

Health Imaging

Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Society for Cardiovascular Angiography Interventions (SCAI)

Contrast injections during angiography, PCI unlikely to cause coronary injuries

Charles E. Mullins remembered as a pioneer of interventional pediatric cardiology

Cardiologists reflect on developing primary PCI in face of criticism and pushback

Cardiology societies push Medicare to pay for tricuspid TEER

SCAI shares STEMI recommendations for cardiologists and cath labs

Around the web